Fibroadenoma natural history, complications and prognosis: Difference between revisions
| Line 8: | Line 8: | ||
* The risk of [[malignant]] transformation is extremely low, where it has been reported in only 0.0125% of the cases. | * The risk of [[malignant]] transformation is extremely low, where it has been reported in only 0.0125% of the cases. | ||
* Fibroadenomas commonly enlarge during [[pregnancy]] and involute after the age of [[menopause]]. | * Fibroadenomas commonly enlarge during [[pregnancy]] and involute after the age of [[menopause]]. | ||
* More than 70% of fibroadenomas present as a single mass, and 10%–25% of fibroadenomas present as multiple masses.<ref name="pmid26366109">{{cite journal |vauthors=Lee M, Soltanian HT |title=Breast fibroadenomas in adolescents: current perspectives |journal=Adolesc Health Med Ther |volume=6 |issue= |pages=159–63 |date=2015 |pmid=26366109 |pmc=4562655 |doi=10.2147/AHMT.S55833 |url=}}</ref> | |||
==Complications== | ==Complications== | ||
* Fibroadenoma is a benign tumor that rarely develops any complications.<ref name="radio">Fibroadenoma. Radiopaedia (2015) http://radiopaedia.org/articles/fibroadenoma-of-the-breast-1 Accessed on January, 29 2016</ref> | * Fibroadenoma is a benign tumor that rarely develops any complications.<ref name="radio">Fibroadenoma. Radiopaedia (2015) http://radiopaedia.org/articles/fibroadenoma-of-the-breast-1 Accessed on January, 29 2016</ref> | ||
Revision as of 18:05, 14 January 2019
|
Fibroadenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fibroadenoma natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Fibroadenoma natural history, complications and prognosis |
|
FDA on Fibroadenoma natural history, complications and prognosis |
|
CDC on Fibroadenoma natural history, complications and prognosis |
|
Fibroadenoma natural history, complications and prognosis in the news |
|
Blogs on Fibroadenoma natural history, complications and prognosis |
|
Risk calculators and risk factors for Fibroadenoma natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
Most patients with fibroadenoma are asymptomatic. If left untreated, patients with fibroadenoma may progress to develop a painless, mobile, and well-circumscribe breast lump. Fibroadenoma is a benign tumor that rarely develops any complications. Fibroadenomas commonly enlarge during pregnancy and involute after the age of menopause. The prognosis is generally excellent, and the 5-year survival rate of patients with fibroadenoma is almost equal to the normal population.[1]
Natural History
- Most patients with fibroadenoma are asymptomatic. If left untreated, patients with fibroadenoma may progress to develop a painless, mobile, and well-circumscribe breast lump.[1]
- The risk of malignant transformation is extremely low, where it has been reported in only 0.0125% of the cases.
- Fibroadenomas commonly enlarge during pregnancy and involute after the age of menopause.
- More than 70% of fibroadenomas present as a single mass, and 10%–25% of fibroadenomas present as multiple masses.[2]
Complications
- Fibroadenoma is a benign tumor that rarely develops any complications.[1]
Prognosis
- The prognosis is generally excellent, and the 5-year survival rate of patients with fibroadenoma is almost equal to the normal population.[1]
- In adolescents, the mass regresses completely between 10 and 40% of the time.[3]
References
- ↑ 1.0 1.1 1.2 1.3 Fibroadenoma. Radiopaedia (2015) http://radiopaedia.org/articles/fibroadenoma-of-the-breast-1 Accessed on January, 29 2016
- ↑ Lee M, Soltanian HT (2015). "Breast fibroadenomas in adolescents: current perspectives". Adolesc Health Med Ther. 6: 159–63. doi:10.2147/AHMT.S55833. PMC 4562655. PMID 26366109.
- ↑ Cerrato F, Labow BI (February 2013). "Diagnosis and management of fibroadenomas in the adolescent breast". Semin Plast Surg. 27 (1): 23–5. doi:10.1055/s-0033-1343992. PMC 3706050. PMID 24872735.